Related Experiment Video
Updated: Jun 10, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Risk factors for cerebral palsy in term birth infants
W Kułak1, B Okurowska-Zawada, D Sienkiewicz
1Department of Pediatric Rehabilitation, Medical University in Białystok, Poland. kneur2@wp.pl
Advances in Medical Sciences
|August 7, 2010
Summary
Identifying antenatal, intrapartum, and neonatal risk factors for cerebral palsy (CP) in term infants is crucial. This study highlights pre-eclampsia, placental issues, birth asphyxia, and neonatal complications as significant contributors to CP etiology.
Area of Science:
- Pediatrics
- Neurology
- Obstetrics
Background:
- Cerebral palsy (CP) is a significant developmental disorder.
- Identifying risk factors is key to prevention and early intervention strategies.
Purpose of the Study:
- To identify antenatal, intrapartum, and neonatal risk factors for cerebral palsy (CP) in term birth infants.
- To analyze these factors within a hospital-based cohort.
Main Methods:
- Retrospective review of medical records for 213 children with CP and 280 controls.
- Study included live births over 36 weeks gestation between 1990 and 2005.
- Comparison of antenatal, intrapartum, and neonatal events between CP cases and controls.
Main Results:
- Male infants constituted 57% of the CP group.
- Spastic tetraplegia and spastic hemiplegia were the most common CP types.
- Antenatal/intrapartum risks: pre-eclampsia, abruptio placenta, placenta previa. Birth asphyxia was significantly higher in CP infants (p<0.001).
- Neonatal risks: respiratory distress syndrome, meningitis, and neonatal seizures were associated with increased CP incidence.
Conclusions:
- Confirms multiple antenatal, intrapartum, and neonatal factors contribute to the etiology of cerebral palsy in term infants.
- Highlights the importance of monitoring and managing these risk factors during pregnancy and delivery.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:30Neurulation
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...